SEBI Secretarial Compliance Report for the year ended 31.03.2026

Vista Pharmaceuticals Ltd has submitted its Annual Secretarial Compliance Report for FY 2025-26 to BSE under SEBI LODR Regulation 24A. The report was prepared by Practicing Company Secretary Aakanksha Dubey & Co. The examination covered compliance with SEBI Act, SCRA, LODR Regulations, SAST Regulations, PIT Regulations, and Depositories Regulations. The company has reported full compliance across all 11 parameters checked, including secretarial standards, board policies, website disclosures, director disqualification checks, related party transactions, and insider trading norms. No deviations, violations, or penalties were reported. The previous year's report also contained no observations. No actions were taken by SEBI or stock exchanges against the company during the review period.